Literature DB >> 16040219

Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter.

Andreas Neher1, Hannes Fischer, Elisabeth Appenroth, Cornelia Lass-Flörl, Astrid Mayr, Andreas Gschwendtner, Hanno Ulmer, Thaddaeus F Gotwald, Michaela Gstöttner, Vladimir Kozlov, Markus Nagl.   

Abstract

OBJECTIVES: A rational approach in the treatment of chronic rhinosinusitis (CRS) is the intranasal application of antiseptic agents, due to the pathogenetic role of bacteria and fungi. N-Chlorotaurine (NCT), a mild endogenous oxidant with broad-spectrum antimicrobial activity, has been tested for the first time in CRS.
METHODS: This one-arm phase IIa clinical study is the first step in the clinical development of this promising substance for local therapy of CRS. The nasal and paranasal cavities of 12 patients were rinsed with 10-20 ml of 1% aqueous NCT solution, applied via a novel catheter system (YAMIK). Treatment consisted of three lavages per week for 4 weeks.
RESULTS: NCT caused neither alterations of the mucosa nor burning pain during application. Nevertheless, the insertion of the catheter, the insufflation of the posterior cuff and the overpressure inside the sinuses after infiltration led to moderate pain in some patients. Mucosal swelling decreased in all subjects, nasal breathing could be improved in nine patients and impaired olfaction in seven. Polyps did not disappear within the 1-month period of the study.
CONCLUSIONS: The good tolerability and possible beneficial effects of NCT encourage its further investigation in CRS. Despite some limitations the YAMIK catheter proved to be a convenient and safe device for rinsing the nasal and paranasal sinuses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040219     DOI: 10.1016/j.anl.2005.05.006

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  10 in total

1.  [Therapy-resistant otitis externa with additional tympanic membrane perforation: local therapy using N-chlorotaurine and dexamethasone].

Authors:  M Lumassegger; M Nagl; C Pototschnig; A Neher
Journal:  HNO       Date:  2010-09       Impact factor: 1.284

2.  Effect of N-chlorotaurine mouth rinses on plaque regrowth and plaque vitality.

Authors:  K Lorenz; D Mayer; G Bruhn; B Noack; M Brecx; C Heumann; H Toutenburg; L Netuschil; M Nagl; W Gottardi; T Hoffmann
Journal:  Clin Oral Investig       Date:  2008-06-27       Impact factor: 3.573

Review 3.  N-chloramines, a promising class of well-tolerated topical anti-infectives.

Authors:  Waldemar Gottardi; Dmitri Debabov; Markus Nagl
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

4.  Bactericidal and Fungicidal Activity of N-Chlorotaurine Is Enhanced in Cystic Fibrosis Sputum Medium.

Authors:  Martina Gruber; Ivan Moser; Markus Nagl; Michaela Lackner
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 5.  Update on Intranasal Medications in Rhinosinusitis.

Authors:  Kornkiat Snidvongs; Sanguansak Thanaviratananich
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

Review 6.  Current Opinion on the Therapeutic Capacity of Taurine-Containing Halogen Derivatives in Infectious and Inflammatory Diseases.

Authors:  Janusz Marcinkiewicz; Markus Nagl; Anthony Kyriakopoulos; Maria Walczewska; Magdalena Skóra; Paulina Skalska
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

7.  Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye--a phase 1 clinical study.

Authors:  Barbara Teuchner; Eduard Schmid; Hanno Ulmer; Waldemar Gottardi; Markus Nagl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-12       Impact factor: 3.117

8.  N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.

Authors:  Michaela Lackner; Ulrike Binder; Martin Reindl; Beyhan Gönül; Hannes Fankhauser; Christian Mair; Markus Nagl
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

Review 9.  N-Chlorotaurine, a Promising Future Candidate for Topical Therapy of Fungal Infections.

Authors:  Markus Nagl; Roland Arnitz; Michaela Lackner
Journal:  Mycopathologia       Date:  2017-07-12       Impact factor: 2.574

10.  Tolerability of inhaled N-chlorotaurine in the pig model.

Authors:  Ralf Geiger; Benedikt Treml; Anna Pinna; Linn Barnickel; Harald Prossliner; Hannes Reinstadler; Michael Pilch; Maria Hauer; Christoph Walther; Hans-Jörg Steiner; Thomas Giese; Andreas Wemhöner; Sabine Scholl-Bürgi; Waldemar Gottardi; Roland Arnitz; Consolato Sergi; Markus Nagl; Alexander Löckinger
Journal:  BMC Pulm Med       Date:  2009-07-14       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.